Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis and systemic sclerosis; FB825, which is in Phase II clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, a human monoclonal antibody, which is in pre-clinical stage for the treatment of allergic asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and sale of agricultural products. The company was incorporated in 2008 and is headquartered in Taipei City, Taiwan.
Oneness Biotech Dividend Announcement
• Oneness Biotech announced a annually dividend of NT$0.11 per ordinary share which will be made payable on 2023-07-21. Ex dividend date: 2023-06-16
• Oneness Biotech annual dividend for 2023 was NT$0.11
• Oneness Biotech's trailing twelve-month (TTM) dividend yield is -%
Oneness Biotech Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-06-16 | NT$0.11 | annually | 2023-07-21 |
2015-08-24 | NT$0.09 | annually | |
2014-08-25 | NT$0.15 | annually | |
2012-09-06 | NT$0.11 | annually |
Oneness Biotech Dividend per year
Oneness Biotech Dividend Yield
Oneness Biotech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Oneness Biotech stock? Use our calculator to estimate your expected dividend yield:
Oneness Biotech Financial Ratios
Oneness Biotech Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Oneness Biotech stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.